Central retinal vein occlusion post-COVID-19 vaccination

Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives all across the world, there are a few case reports on post-vaccine thrombotic events seen with the AZD1222, ChAdO × 1 vaccine. Here, we prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonawane, Nikita J, Yadav, Divya, Kota, Annaji Rao, Singh, Harsh Vardhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Expedited Publications, Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917569/
https://www.ncbi.nlm.nih.gov/pubmed/34937265
http://dx.doi.org/10.4103/ijo.IJO_1757_21
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives all across the world, there are a few case reports on post-vaccine thrombotic events seen with the AZD1222, ChAdO × 1 vaccine. Here, we present two cases of central retinal vein occlusion presenting immediately after receiving the second dose of the Covishield vaccine. Although the causal relationship cannot be drawn, the ophthalmologist should be aware of this adverse reaction.

Ejemplares similares